Myriad ruling muddied by ACLU petition
A petition for rehearing by the Federal Circuit filed last week by the plaintiffs in the Myriad case reveals how the court’s analysis could further complicate the landscape for gene patents
The petition, filed by the American Civil Liberties Union and the Public Patent Foundation on behalf of the plaintiffs in Association for Molecular Pathology v the USPTO and Myriad Genetics, claims that the majority opinion erred on two key points.
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.